User profiles for Charlotte Yong-Hing

Charlotte J Yong-Hing

Clinical Associate Professor, Faculty of Medicine, University of British Columbia
Verified email at bccancer.bc.ca
Cited by 1268

Dual-energy CT as a potential new diagnostic tool in the management of gout in the acute setting

S Nicolaou, CJ Yong-Hing… - American Journal of …, 2010 - Am Roentgen Ray Soc
OBJECTIVE. Gout is the most common crystal deposition arthropathy currently diagnosed
clinically and with arthrocentesis. Dual-energy CT is a promising new imaging technique …

Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with …

S Ezziddin, M Attassi, CJ Yong-Hing… - Journal of nuclear …, 2014 - Soc Nuclear Med
Outcome analyses for patients with gastroenteropancreatic neuroendocrine tumors (GEP NET)
after peptide receptor radionuclide therapy (PRRT) are still limited, especially with regard …

Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain

CJ YongHing, A Obenaus, R Stryker… - … in Medicine: An …, 2005 - Wiley Online Library
The temporal magnetic resonance (MR) appearance of human brain tissue during formalin
fixation was measured and modeled using a diffusion mathematical model of formalin fixation…

Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?

S Ezziddin, J Lohmar, CJ Yong-Hing… - Clinical nuclear …, 2012 - journals.lww.com
Purpose Selection of candidates for peptide receptor radionuclide therapy (PRRT) is
increasingly based on receptor positron emission tomography (PET) imaging, including the …

Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors

S Ezziddin, T Logvinski, C Yong-Hing… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Radiolabeled octreotide analogs (Oct) and metaiodobenzylguanidine (MIBG) offer 2 different
approaches for imaging and targeting metastatic gastroenteropancreatic neuroendocrine …

Role of imaging in penetrating and blunt traumatic injury to the heart

SJ Co, CJ Yong-Hing, S Galea-Soler, B Ruzsics… - Radiographics, 2011 - pubs.rsna.org
Cardiac injury due to blunt or penetrating chest trauma is common and is associated with
significant morbidity and mortality. Understanding the mechanisms, types, and complications of …

COVID-19: safe guidelines for breast imaging during the pandemic

JM Seely, AM Scaranelo, C Yong-Hing… - Canadian …, 2020 - journals.sagepub.com
During the COVID-19 pandemic, breast imaging must be performed using safe practices.
Balancing the need to avoid delays in the diagnosis of breast cancer while avoiding infection …

Response and long-term control of bone metastases after peptide receptor radionuclide therapy with 177Lu-octreotate

…, A Sabet, F Heinemann, CJ Yong-Hing… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Peptide receptor radionuclide therapy (PRRT) is an efficient treatment for gastroenteropancreatic
neuroendocrine tumors (GEP NETs), with outstanding overall response rates and …

Recommendations for improving Canadian radiology equity, diversity and inclusion

…, T Hillier, K Darras, C Yong-Hing - Canadian …, 2023 - journals.sagepub.com
Improving equity, diversity, and inclusion (EDI) within Canadian radiology is critical for optimal
patient care and to reduce health disparities. Although there are increasing national EDI …

The status of diversity in Canadian radiology—where we stand and what can we do about it

…, KE Darras, CJ Yong-Hing - Canadian …, 2021 - journals.sagepub.com
Radiology has been identified as one of the medical specialties with the least gender, racial,
and ethnic diversity. Despite the demonstrated benefits of gender and race diversity in …